Neoplasms and Thoracic Oncology

At Assistance Publique Hopitaux De Paris, the clinical research portfolio is centered on cancer, with a strong focus on extensive stage small cell lung cancer. The trials in this area are designed to evaluate whether new treatment approaches can improve survival and disease control for patients with advanced lung malignancies.

• Studies in small cell lung cancer are assessing whether adding new therapies can extend overall survival and strengthen first-line treatment options.
• Research in thoracic oncology is focused on improving the effectiveness of care for patients with aggressive lung cancer.
• The trials aim to test innovative immunotherapy-based strategies against standard treatment alone.

With 6 trials and 44 investigators, the Service Oncologie Thoracique is contributing to research that explores better ways to treat advanced neoplasms and improve outcomes for people with difficult-to-treat lung cancer.